Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials

By sjmartinez • February 11, 2023

Langley RG, Sofen H, Dei-Cas I, Reich K, Sigurgeirsson B, Warren RB, Paul C, Szepietowski JC, Tsai TF, Hampele I, You R, Charef P, Papavassilis C. Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials. Br J Dermatol. 2023 Feb 10;188(2):198-207. doi: 10.1093/bjd/ljac040. PMID: 36763857.

Tags: Dermatology, Publications

Emergency versus Outpatient Care for Pediatric Atopic Dermatitis: A Population-Based Study of Sociodemographic Factors and Health Care Utilization

Yamamoto RK, Tolson HC, Hao A, Kikuchi R, Sadrolashrafi K, Guo L, Bilimoria SN, Yee D, Armstrong AW. Emergency versus Outpatient Care for Pediatric Atopic[...]

Recurrent and Infiltrative Basal Cell Carcinoma of the Nose After High-Dose Rate Electronic Brachytherapy

Park A, Castillo J. Recurrent and Infiltrative Basal Cell Carcinoma of the Nose After High-Dose Rate Electronic Brachytherapy. Dermatol Surg. 2025 Jul 15. doi: 10.1097/DSS.0000000000004773.[...]

Phase I Trial to Evaluate the Safety of Intralesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

Wang CJ, Bang A, Chowdhury S, Leslie KS, Lang UE, Shimoda M, Henrich TJ, Hoh R, Deeks SG, Wang C, Deitchman AN, Couey P, Maurer[...]